Synageva
is a biopharmaceutical firm that focuses on discovery, development and commercialization of therapeutic products for rare diseases... Read moreSynageva
is a biopharmaceutical firm that focuses on discovery, development and commercialization of therapeutic products for rare diseases... Read more
CEO
Add
News
Jan 30, 2017
BioPortfolio
Synageva: Synageva BioPharma Corp Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Dec 21, 2016
PharmiWeb
Synageva: Sanj K. Patel to Introduce Kiniksa Pharmaceuticals at 35th Annual J.P. Morgan Healthcare Conference
Nov 25, 2016
BioPortfolio
Synageva: Synageva BioPharma Corp. formerly AviGenics Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350
Mar 17, 2016
MarketWatch
Synageva: 4 beaten-down Internet companies that are takeover targets
Sep 01, 2015
REUTERS
Synageva: UPDATE 1-Alexion gets EU approval for drug acquired in Synageva deal
Aug 10, 2015
AMERICAN BANKING NEWS
Synageva: Synageva Biopharma Corp Receives Average Rating of "Hold" from Analysts (NASDAQ:GEVA)
Aug 10, 2015
PR-INSIDE.COM
Press Release: Synageva : Synageva BioPharma Corp. (formerly AviGenics, Inc.) - New Report Available
Aug 08, 2015
PR-INSIDE.COM
Press Release: Synageva : Report Published: "Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review"
Jul 07, 2015
DAKOTA FINANCIAL NEWS
Synageva: Synageva Biopharma Corp Given Average Recommendation of "Hold" by Analysts (NASDAQ:GEVA)
Jun 24, 2015
MIDEASTTIME
Synageva: Synageva Biopharma Corp Receives Hold Rating from Canaccord Genuity (GEVA)
Synageva Competitors
1
2
3
4
5
6
7
8